Anaeropharma Science, Inc.

Seventure Partners is doubling down in the microbiome space with a new €200m fund Health for Life Capital II (HFL II). With 90% of limited partners from the first fund returning to back the new fund,

Founded in 2004 and now with around 20 employees, privately held Japanese venture Anaeropharma Science Inc. is pursuing what it says is a novel approach globally to the bacteria-mediated delivery of

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in